GlassScriptPhysician profile
Roy H Trawick
NPI 1609800945
$923.74
in general payments reported to CMS, 2019-2025
13 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $16.92 · 2021: $146 · 2022: $29.94 · 2023: $258 · 2024: $40.71 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $270.53 | 2019-2025 | Dynacord, Truespan Orthocord, Healix Knotless Peek |
| Ortho Development Corporation | $122.63 | 2021 | |
| Linvatec Corporation | $115.30 | 2023 | Biobrace 23mm |
| Medacta USA, INC. | $93.13 | 2023 | Gmk Sphere |
| Vertex Pharmaceuticals Incorporated | $87.97 | 2024-2025 | |
| Pfizer INC. | $48.38 | 2019-2022 | |
| Pacira Therapeutics, INC. | $45.50 | 2019 | |
| Ferring Pharmaceuticals INC. | $43.96 | 2019 | |
| Orthofix Medical, INC. | $29.34 | 2023 | Physio-Stim |
| Boston Scientific Corporation | $20.30 | 2023 | |
| Bioventus LLC | $16.92 | 2020 | |
| Janssen Pharmaceuticals, INC | $16.39 | 2022 | |
| Solventum Corporation | $13.39 | 2024 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Trawick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.